Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × trifluridine tipiracil drug combination × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Stomach Neoplasms 2 Rectal Neoplasms 2 Colonic Neoplasms 2 Advanced Solid Tumors 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Microsatellite-stable Colorectal Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gallbladder Neoplasms 1 Digestive System Diseases 1 Colorectal Cancer Metastatic 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Advanced/Metastatic Solid Tumors 1 Advanced Gastric Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 10 Nivolumab 9 enfortumab vedotin 8 avelumab 8 atezolizumab 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Cystectomy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡